Par Pharmaceutical Companies, Inc. (PRX)
PRX Stock Report
PRX News
Related Blogs

The Latest Financial News
View All Par Pharmaceutical Companies, Inc. Stock News
| No commentary found for Commentary Missing |
Key Fundamentals
| Price (3/19 4:00PM) | $25.23 |
|---|---|
| Volume (3/19 4:00PM) | 370,534 |
| Last Close Price | $25.23 |
| 10 Day Average Volume | 404,500 |
| 13 Week Price Range | $23.09 - $27.93 |
| 52 Week Price Range | $8.57 - $27.93 |
| LTM Revenue | $1.2 Billion |
| Shares Outstanding (12/2009) | 34.9 Million |
| Market Capitalization | $881.5 Million |
| Shares Held By Institutions | 32.0 Million |
| Institutional Holders | 191 |
| % Shares Held By Institutions | 92.20% |
| Earnings Per Share (EPS) | $2.25 |
| P/E Ratio | 11.20 |
| Book Value Per Share | $14.27 |
| Gross Margin | 31.00% |
| Annual Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Beta | 0.73 |
| Fiscal Year Ends | December |
About Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Companies, Inc. is considered to operate in the Healthcare sector. They specifically operate in the Drugs - Generic business segment contained within the Drugs industry.
The Company, through its wholly owned subsidiary, is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.


